- Mckinnon C, Tabrizi SJ (2014) The ubiquitin-
proteasome system in neurodegeneration.
Antioxid Redox Signal 5:1–61 - Wang G, Fersht AR (2017) Multisite
aggregation of p53 and implications for drug
rescue. Proc Natl Acad Sci U S A 114
(13):2634–2643 - Mathias Jucker LCW (2013) Self-propagation
of pathogenic aggregates in neurodegenerative
diseases. Nature 501:45–51 - Johnson SM, Connelly S, Fearns C, Powers
ET, Kelly JW (2012) The transthyretin amyloi-
doses: from delineating the molecular mecha-
nism of aggregation linked to pathology to a
regulatory agency approved drug. J Mol Biol
421:185–203 - Gallardo R, Ramakers M, De Smet F et al
(2016) De novo design of a biologically active
amyloid. Science 354:720–730 - Walsh G (2014) Biopharmaceutical bench-
marks 2014. Nat Biotechnol 32:992–1000 - Hamrang Z, Rattray NJW, Pluen A (2013)
Proteins behaving badly: emerging technolo-
gies in profiling biopharmaceutical aggrega-
tion. Trends Biotechnol 31:448–458 - Kumar S, Singh SK, Wang X, Rup B, Gill D
(2011) Coupling of aggregation and immuno-
genicity in biotherapeutics: T- and B-cell
immune epitopes may contain aggregation-
prone regions. Pharm Res 28:949–961 - Wang W, Singh SK, Li N, Toler MR, King KR,
Nema S (2012) Immunogenicity of protein
aggregates – concerns and realities. Int J
Pharm 431:1–11 - Roberts CJ (2008) Protein aggregation and its
impact on product quality. Curr Opin Biotech-
nol 23:1–7 - Knowles TP, Fitzpatrick AW, Meehan S, Mott
HR, Vendruscolo M, Dobson CM, Welland
ME (2007) Role of intermolecular forces in
defining material properties of protein nanofi-
brils. Science 318:1900–1903 - Li D, Jones EM, Sawaya MR et al (2014)
Structure-based design of functional amyloid
materials. J Am Chem Soc 136:18044–18051 - Hauser CAE, Maurer-Stroh S, Martins IC
(2014) Amyloid-based nanosensors and nano-
devices. Chem Soc Rev 43:5326–5345 - Shimanovich U, Efimov I, TO M et al (2014)
Protein microgels from amyloid fibril net-
works. ACS Nano 9:43–51 - Kamada A, Mittal N, So ̈derberg LD,
Ingverud T, Ohm W, Roth SV, Lundell F, Len-
del C (2017) Flow-assisted assembly of nanos-
tructured protein microfibers. Proc Natl Acad
Sci U S A 114:1232–1237
27. Lee CC, Perchiacca JM, Tessier PM (2013)
Toward aggregation-resistant antibodies by
design. Trends Biotechnol 31:612–620
28. Dudgeon K, Rouet R, Kokmeijer I,
Schofield P, Stolp J, Langley D, Stock D, Christ
D (2012) General strategy for the generation
of human antibody variable domains with
increased aggregation resistance. Proc Natl
Acad Sci U S A 109:10879–10884
29. Perchiacca JM, Tessier PM (2012) Engineering
aggregation-resistant antibodies. Annu Rev
Chem Biomol Eng 3:263–286
30. Van der Kant R, Karow-Zwick AR, Van Durme
J et al (2017) Prediction and reduction of the
aggregation of monoclonal antibodies. J Mol
Biol 429:1244–1261
31. Belli M, Ramazzotti M, Chiti F (2011) Predic-
tion of amyloid aggregation in vivo. EMBO
Rep 12:657–663
32. Buck PM, Kumar S, Singh SK (2013) On the
role of aggregation prone regions in protein
evolution, stability, and enzymatic catalysis:
insights from diverse analyses. PLoS Comput
Biol 9:e1003291
33. Zambrano R, Jamroz M, Szczasiuk A, Pujols J,
Kmiecik S, Ventura S (2015) AGGRES-
CAN3D (A3D): server for prediction of aggre-
gation properties of protein structures. Nucleic
Acids Res 43:w306–w313
34. Conchillo-Sole ́O, de Groot NS, Avile ́s FX,
Vendrell J, Daura X, Ventura S (2007)
AGGRESCAN: a server for the prediction
and evaluation of ‘hot spots’ of aggregation in
polypeptides. BMC Bioinformatics 8:65
35. Jamroz M, Kolinski A, Kmiecik S (2013)
CABS-flex: server for fast simulation of protein
structure fluctuations. Nucleic Acids Res
41:427–431
36. Lee B, Richards FM (1971) The interpretation
of protein structures: estimation of static acces-
sibility. J Mol Biol 55:379–400
37. Schymkowitz J, Borg J, Stricher F, Nys R,
Rousseau F, Serrano L (2005) The FoldX web
server: an online force field. Nucleic Acids Res
33:382–388
38. Dutta SR, Gauri SS, Ghosh T, Halder SK, Das-
Mohapatra PK, Mondal KC, Ghosh AK (2017)
Elucidation of structural and functional inte-
gration of a novel antimicrobial peptide from
Antheraea mylitta. Bioorg Med Chem Lett
27:1686–1692
39. Polo A, Colonna G, Guariniello S, Ciliberto G,
Costantini S (2016) Deducing the functional
characteristics of the human selenoprotein
SELK from the structural properties of its
intrinsically disordered C-terminal domain.
Mol Biosyst 12(3):758–772
442 Jordi Pujols et al.